135 related articles for article (PubMed ID: 26083365)
21. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
[TBL] [Abstract][Full Text] [Related]
22. Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.
Bouchareb R; Mahmut A; Nsaibia MJ; Boulanger MC; Dahou A; Lépine JL; Laflamme MH; Hadji F; Couture C; Trahan S; Pagé S; Bossé Y; Pibarot P; Scipione CA; Romagnuolo R; Koschinsky ML; Arsenault BJ; Marette A; Mathieu P
Circulation; 2015 Aug; 132(8):677-90. PubMed ID: 26224810
[TBL] [Abstract][Full Text] [Related]
23. Placental autotaxin expression is diminished in women with pre-eclampsia.
Ichikawa M; Nagamatsu T; Schust DJ; Kawai-Iwasawa Y; Kawana K; Yamashita T; Osuga Y; Aoki J; Yatomi Y; Fujii T
J Obstet Gynaecol Res; 2015 Sep; 41(9):1406-11. PubMed ID: 26111716
[TBL] [Abstract][Full Text] [Related]
24. Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.
Pleli T; Martin D; Kronenberger B; Brunner F; Köberle V; Grammatikos G; Farnik H; Martinez Y; Finkelmeier F; Labocha S; Ferreirós N; Zeuzem S; Piiper A; Waidmann O
PLoS One; 2014; 9(7):e103532. PubMed ID: 25062038
[TBL] [Abstract][Full Text] [Related]
25. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
[TBL] [Abstract][Full Text] [Related]
26. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta.
Iwasawa Y; Fujii T; Nagamatsu T; Kawana K; Okudaira S; Miura S; Matsumoto J; Tomio A; Hyodo H; Yamashita T; Oda K; Kozuma S; Aoki J; Yatomi Y; Taketani Y
Am J Reprod Immunol; 2009 Aug; 62(2):90-5. PubMed ID: 19614625
[TBL] [Abstract][Full Text] [Related]
27. A novel enzyme immunoassay for the determination of phosphatidylserine-specific phospholipase A(1) in human serum samples.
Nakamura K; Igarashi K; Ohkawa R; Saiki N; Nagasaki M; Uno K; Hayashi N; Sawada T; Syukuya K; Yokota H; Arai H; Ikeda H; Aoki J; Yatomi Y
Clin Chim Acta; 2010 Aug; 411(15-16):1090-4. PubMed ID: 20388504
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.
Nakasaki T; Tanaka T; Okudaira S; Hirosawa M; Umemoto E; Otani K; Jin S; Bai Z; Hayasaka H; Fukui Y; Aozasa K; Fujita N; Tsuruo T; Ozono K; Aoki J; Miyasaka M
Am J Pathol; 2008 Nov; 173(5):1566-76. PubMed ID: 18818380
[TBL] [Abstract][Full Text] [Related]
29. Serum Autotaxin/ENPP2 correlates with insulin resistance in older humans with obesity.
Reeves VL; Trybula JS; Wills RC; Goodpaster BH; Dubé JJ; Kienesberger PC; Kershaw EE
Obesity (Silver Spring); 2015 Dec; 23(12):2371-6. PubMed ID: 26727116
[TBL] [Abstract][Full Text] [Related]
30. Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding.
Stein AJ; Bain G; Prodanovich P; Santini AM; Darlington J; Stelzer NM; Sidhu RS; Schaub J; Goulet L; Lonergan D; Calderon I; Evans JF; Hutchinson JH
Mol Pharmacol; 2015 Dec; 88(6):982-92. PubMed ID: 26371182
[TBL] [Abstract][Full Text] [Related]
31. [The Laboratory Medicine of Lipid Mediators].
Yatomi Y
Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
[TBL] [Abstract][Full Text] [Related]
32. Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer.
Barbayianni E; Kaffe E; Aidinis V; Kokotos G
Prog Lipid Res; 2015 Apr; 58():76-96. PubMed ID: 25704398
[TBL] [Abstract][Full Text] [Related]
33. Increased autotaxin activity in multiple sclerosis.
Zahednasab H; Balood M; Harirchian MH; Mesbah-Namin SA; Rahimian N; Siroos B
J Neuroimmunol; 2014 Aug; 273(1-2):120-3. PubMed ID: 24984830
[TBL] [Abstract][Full Text] [Related]
34. Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe.
Kawaguchi M; Okabe T; Okudaira S; Nishimasu H; Ishitani R; Kojima H; Nureki O; Aoki J; Nagano T
ACS Chem Biol; 2013 Aug; 8(8):1713-21. PubMed ID: 23688339
[TBL] [Abstract][Full Text] [Related]
35. Autotaxin as a novel, tissue-remodeling-related factor in regressing corpora lutea of cycling rats.
Masuda K; Haruta S; Orino K; Kawaminami M; Kurusu S
FEBS J; 2013 Dec; 280(24):6600-12. PubMed ID: 24128332
[TBL] [Abstract][Full Text] [Related]
36. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
[TBL] [Abstract][Full Text] [Related]
37. Urinary autotaxin concentrations are associated with kidney injury.
Morita Y; Kurano M; Morita E; Shimamoto S; Igarashi K; Sawabe M; Aoki J; Yatomi Y
Clin Chim Acta; 2020 Oct; 509():156-165. PubMed ID: 32540127
[TBL] [Abstract][Full Text] [Related]
38. Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.
Joshita S; Umemura T; Usami Y; Yamashita Y; Norman GL; Sugiura A; Yamazaki T; Fujimori N; Kimura T; Matsumoto A; Igarashi K; Yoshizawa K; Ota M; Tanaka E
Sci Rep; 2018 May; 8(1):8159. PubMed ID: 29802350
[TBL] [Abstract][Full Text] [Related]
39. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
[TBL] [Abstract][Full Text] [Related]
40. Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.
Pradère JP; Tarnus E; Grès S; Valet P; Saulnier-Blache JS
Biochim Biophys Acta; 2007 Jan; 1771(1):93-102. PubMed ID: 17208043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
